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Abstract
Background: The proportion of extrapulmonary tuberculosis (EPTB) reported in the United
States has been gradually increasing. HIV infection and foreign birth are increasingly associated with
tuberculosis and understanding their effect on the clinical presentation of tuberculosis is important.
Methods: Case-control study of 6,124 persons with tuberculosis reported to the North Carolina
Division of Public health from January 1, 1993 to December 31, 2006. Multivariate logistic
regression was used to obtain adjusted odds ratios measuring the associations of foreign birth
region and US born race/ethnicity, by HIV status, with EPTB.
Results: Among all patients with tuberculosis, 1,366 (22.3%) had EPTB, 563 (9.2%) were HIV co-
infected, and 1,299 (21.2%) were foreign born. Among HIV negative patients, EPTB was associated
with being foreign born (adjusted ORs 1.36 to 5.09, depending on region of birth) and with being
US born, Black/African American (OR 1.84; 95% CI 1.42, 2.39). Among HIV infected patients, EPTB
was associated with being US born, Black/African American (OR 2.60; 95% CI 1.83, 3.71) and with
foreign birth in the Americas (OR 5.12; 95% CI 2.84, 9.23).
Conclusion: Foreign born tuberculosis cases were more likely to have EPTB than US born
tuberculosis cases, even in the absence of HIV infection. Increasing proportions of foreign born and
HIV-attributable tuberculosis cases in the United States will likely result in a sustained burden of
EPTB. Further research is needed to explore why the occurrence and type of EPTB differs by
region of birth and whether host genetic and/or bacterial variation can explain these differences in
EPTB.
Background
The incidence of tuberculosis (TB) in the United States
(US) has been declining over the past decades except for a
resurgence from 1985 to 1992 (Figure 1) [1,2]. In 2006,
the number of TB cases in the US reached an all-time low
with 13,779 new cases, corresponding to an incidence of
4.6 cases/100,000 persons [3]. The decline in extrapulmo-
nary TB (EPTB) has not been as great as for pulmonary TB
(PTB). Consequently, the proportion of EPTB cases has
increased from 13.5% of all reported TB cases in 1975 to
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21.0% in 2006 (Figure 1) [3-6]. This relative increase may
be an underestimate due to recent changes in case defini-
tions, as cases with concomitant pulmonary disease or
miliary disease are now counted as PTB cases [3-6].
Several studies have observed that the proportion of EPTB
is higher among HIV co-infected individuals [7-11] and
foreign born immigrants [8,9,12,13]. The latter popula-
tion currently accounts for over half of all TB cases in the
US [3].
Few studies have quantified the independent effect of HIV
and foreign birth on EPTB and none have analyzed their
joint association with EPTB. In this study, we investigated
the association of HIV and foreign birth location, both
individually and jointly, with the occurrence of EPTB
among reported TB cases in North Carolina from 1993 to
2006.
Methods
We analyzed all verified TB cases in the North Carolina TB
registry that were reported to the Division of Public
Health from January 1, 1993 through December 31, 2006.
Cases were either laboratory, clinical, or provider verified
using standard definitions from the Centers for Disease
Control and Prevention (CDC) [3]. Demographic infor-
mation, TB risk factors, disease presentation, and diagnos-
tic and treatment information on each case were collected
using the CDC's standardized Report of Verified Case of
Tuberculosis form and entered into the North Carolina
registry.
Variables used
The outcome of interest was EPTB, defined as any verified
TB case whose site(s) of disease was not recorded as "Pul-
monary". Individuals with concomitant PTB and EPTB
were excluded due to insufficient numbers and because
we aimed to analyze the effect of HIV and foreign birth
region on exclusive EPTB.
Exposures of interest included HIV infection, foreign
birth, region of birth, and US born race/ethnicity. HIV sta-
tus was defined as positive, negative, or unknown. Foreign
birth was defined as being born outside of the US or its
Reported tuberculosis cases and proportion by site of disease, United States, 1975–2006 Figure 1
Reported tuberculosis cases and proportion by site of disease, United States, 1975–2006. (Source: References [3–6]).
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territories [3]. US and foreign born TB cases were catego-
rized by race/ethnicity and region of birth, respectively, to
account for differences in TB rates. US TB cases were cate-
gorized as White/Caucasian, Black/African American, His-
panic, or Other (Asian, American Indian, Native Alaskan,
or Pacific Islander). Foreign born cases were classified as
African, American (Central and South America and Carib-
bean), European (including the Middle East and Russia),
Indian (including Pakistan), Southeast Asian, and East
Asian (further detail provided in the accompanying
Appendix).
To allow for a detailed analysis of the association of EPTB
with HIV and foreign birth, both individually and jointly,
HIV status and race/ethnicity or birth region variables
were combined into exclusive categories: HIV positive and
foreign born by region, HIV positive and US born by race/
ethnicity, HIV negative and foreign born by region, and
HIV negative and US born by race ethnicity. US born,
White/Caucasian TB cases who were HIV negative served
as the common referent group.
Statistical Analysis
Crude odds ratios (OR) and ORs from logistic regression
were used to measure the association between each expo-
sure category and EPTB. A final model was derived using
backward elimination [14,15]. Further interactions
beyond HIV infection by race/ethnicity or birth region
were not considered. All covariates were assessed for con-
founding. If the OR changed by more than 10% when a
covariate was removed from the model, that covariate was
considered a confounder and retained in the model [16].
Finally, a year variable was included in the model to
account for increasing implementation of routine HIV
testing during the study period.
All analyses were performed using SAS version 9.1.3. This
study was approved by the Institutional Review Boards at
the North Carolina Department of Public Health, Com-
municable Disease Program and the University of North
Carolina at Chapel Hill.
Results
Patient Characteristics
Between January 1, 1993 and December 31, 2006, a total
of 6,416 verified cases of TB were reported and included
in the North Carolina RVCT registry. Two hundred and
ninety-two cases (4.6%) had both pulmonary and
extrapulmonary disease and were excluded from analysis,
resulting in a final study population of 6,124. Tables 1
and 2 show the distribution of socio-demographic and
clinical variables by TB, HIV, and foreign birth status.
Extrapulmonary TB occurred in 1,366 (22.3%) TB
patients. These cases were more often provider verified,
HIV positive, foreign born, female, and 15 to 24 years old
compared to PTB cases (Table 1). Among the foreign
born, a larger proportion of EPTB cases had been in the US
at least five years prior to TB diagnosis.
HIV co-infection was present in 563 (9.2%) of all TB
cases, 35.5% had unknown HIV status due to testing not
being performed. This decreased from 58.4% in 1993 to
8.1% in 2006. HIV co-infected TB cases were more often
laboratory verified, diagnosed with EPTB, US born, male,
25 to 44 years old, with a recent history of being homeless
and substance abuse in the past year (Table 2).
Foreign born cases accounted for 1,299 (21.2%) of all TB
cases, increasing from 6.3% in 1993 to 37.2% in 2006.
Over 60% came from 5 countries, including Mexico
(38.0%), Vietnam (8.2%), India (6.9%), Philippines
(4.4%), and Honduras (4.1%). Foreign born cases were
more often diagnosed with EPTB, HIV negative, 15 to 44
years old, and lacked TB risk factors such as homelessness,
illicit drug use, and excess alcohol use (Table 2). US born
TB cases were primarily Black/African American (66.6%)
or White/Caucasian (30.5%).
The location of EPTB varied by HIV and foreign birth sta-
tus (Table 3). The most common sites of disease were the
pleura (25.1%) and cervical lymph nodes (15.7%). HIV
co-infected individuals were more likely to have non-cer-
vical lymph node or miliary disease compared to HIV
uninfected individuals, while foreign born EPTB cases
were more likely to have cervical lymphadenitis than US
born cases. The site of EPTB also varied by region of birth
(Figure 2). Lymphatic TB accounted for 50% of EPTB in
East Asia, 47% in India, 45% in Africa, 40% in Southeast
Asia, and 35% in the Americas, but only 17% in Europe/
Middle East, and 21% in the US.
Univariate and Multivariate Analysis
In a crude analysis comparing all foreign born with all US
TB cases, we found that foreign born cases without HIV
infection had a slightly stronger association with EPTB
(OR 1.84; 95%; CI 1.55, 2.18) than US born cases with
HIV infection (OR 1.34; 95% CI 1.06, 1.69). Those who
were both foreign born and had HIV infection had nearly
three times the odds of EPTB compared with HIV unin-
fected US born cases (OR 2.83; 95% CI 1.84, 4.34). Such
generalizations, however, did not reflect the range of asso-
ciations between EPTB and race/ethnicity, geographic
regions, and HIV status.
Results of the detailed analysis are given in Table 4. After
adjusting for year, sex, age, injecting drug use, and alcohol
use, HIV uninfected foreign born cases were more likely to
have EPTB with adjusted ORs ranging from 1.36 to 5.09,
depending on the region of origin. Among US born cases,BMC Public Health 2008, 8:107 http://www.biomedcentral.com/1471-2458/8/107
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only Black/African American ethnicity was associated with
EPTB in the absence of HIV infection (OR 1.84; 95% CI
1.42, 2.39).
HIV infection was also found to be associated with EPTB.
Among US born cases, HIV infection was associated with
EPTB in Black/African Americans (OR 2.60; 95% CI 1.83,
Table 1: Distribution of socio-demographic and clinical characteristics by disease site*.
Socio-demographic and clinical characteristics All TB cases (%) N = 6,124 EPTB (%) N = 1,366 PTB (%) N = 4,758
Verification†
Laboratory 5,143 (84.0) 1.057 (77.4) 4,086 (85.9)
Clinically 742 (12.1) 163 (11.9) 579 (12.2)
Provider diagnosis 239 (3.9) 146 (10.7) 93 (2.0)
HIV status
Positive 563 (9.2) 151 (11.1) 412 (8.7)
Negative 3,388 (55.3) 757 (55.4) 2,631 (55.3)
Not tested 2,173 (35.5) 458 (33.5) 1,715 (36.0)
Foreign-birth status
Foreign 1,299 (21.2) 402 (29.4) 897 (18.9)
United States 4,821 (78.7) 964 (70.6) 3,857 (81.1)
Missing 4 (0.1) 0 (0.0) 4 (0.1)
Sex
Female 2,123 (34.7) 633 (46.3) 1,490 (31.3)
Male 4,001 (65.3) 733 (53.7) 3,268 (68.7)
Time in US‡
0 – 1 years 384 (29.6) 84 (20.9) 300 (33.4)
2 – 5 years 446 (34.3) 136 (33.8) 310 (34.6)
>5 years 443 (34.1) 174 (43.3) 269 (30.0)
Missing 26 (2.0) 8 (2.0) 18 (2.0)
Age (years)
0 – 4 150 (2.5) 29 (2.1) 121 (2.5)
5 – 14 136 (2.2) 33 (2.4) 103 (2.2)
15 – 24 422 (6.9) 112 (8.2) 310 (6.5)
25 – 44 1,872 (30.6) 459 (33.6) 1,413 (29.7)
45 – 64 1,753 (28.6) 334 (24.5) 1,419 (29.8)
65+ 1,790 (39.23) 399 (29,2) 1,391 (29.2)
Missing 1 (0.0) 1 (0.0)
Previous TB disease
Yes 334 (5.5) 70 (5.1) 264 (5.6)
No 5,783 (94.4) 1,293 (94.7) 4,490 (94.4)
Missing 7 (0.1) 3 (0.2) 4 (0.1)
Homeless
Yes 410 (6.7) 35 (2.6) 375 (7.9)
No 5,681 (92.8) 1,321 (96.7) 4,360 (91.6)
Missing 33 (0.5) 10 (0.7) 23 (0.5)
Drug use (injecting)
Yes 98 (1.6) 16 (1.2) 82 (1.7)
No 5,255 (85.8) 1,205 (88.2) 4,050 (85.1)
Missing 771 (12.6) 145 (10.6) 626 (13.2)
Drug use (non-injecting)
Yes 580 (9.5) 71 (5.2) 509 (10.7)
No 4,785 (78.1) 1,150 (84.2) 3,635 (76.4)
Missing 759 (12.4) 145 (10.6) 614 (12.9)
Excess alcohol use
Yes 1,255 (20.5) 124 (9.1) 1,131 (23.8)
No 4,137 (67.6) 1,104 (80.8) 3,033 (63.8)
Missing 732 (12.0) 138 (10.1) 594 (12.5)
* Excluding 292 (4.6%) with concomitant pulmonary and extrapulmonary disease.
† Laboratory: positive M. tuberculosis culture or positive acid-fast stain; Clinical: positive tuberculin skin test, signs and symptoms consistent with TB, 
treatment with TB medication, and a completed diagnostic evaluation; Provider: cases that do not meet the laboratory or clinical case definition, but 
have a clinical picture consistent with TB.
‡ Time in US prior to diagnosis among foreign born cases (n = 1,299).BMC Public Health 2008, 8:107 http://www.biomedcentral.com/1471-2458/8/107
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Table 2: Socio-demographic and clinical characteristics by HIV and foreign birth status*.
Socio-demographic and clinical 
characteristics
HIV+ (%) N = 563 HIV – (%) N = 3,388 Foreign Born (%) N = 1,299 US Born (%) N = 4,821
Verification†
Laboratory 516 (91.7) 2,873 (84.8) 1,070 (82.4) 4,070 (84.4)
Clinical 16 (2.8) 383 (11.3) 163 (12.6) 579 (12.0)
Provider 31 (5.5) 132 (3.9) 66 (5.1) 172 (3.6)
Site of disease
Extrapulmonary 151 (26.8) 757 (22.3) 402 (31.0) 964 (20.0)
Pulmonary 412 (73.2) 2,631 (77.7) 897 (69.0) 3,857 (80.0)
HIV status
Positive 74 (7.8) 471 (9.8)
Negative 943 (72.6) 2,444 (50.7)
Not tested 264 (20.32) 1,906 (39.5)
Foreign-birth status
Foreign 92 (16.3) 943 (27.8)
United States 471 (83.7) 2,444 (72.1)
Missing 0 (0.0) 1 (0.0)
Time in US‡
0 – 1 years 22 (23.9) 271 (28.7)
2 – 5 years 31 (33.7) 351 (37.2)
>5 years 34 (37.0) 305 (32.3)
Missing 5 (5.4) 16 (1.7)
Sex
Female 122 (21.7) 1,101 (32.5) 474 (36.5) 1,649 (34.2)
Male 441 (78.3) 2,287 (67.5) 825 (63.5) 3,172 (65.8)
Age (years)
0 – 4 1 (0.2) 64 (1.9) 17 (1.3) 133 (2.8)
5 – 14 0 (0.0) 37 (1.1) 29 (2.2) 107 (2.2)
15 – 24 11 (2.0) 330 (9.7) 257 (19.8) 165 (3.4)
25 – 44 380 (67.5) 1,272 (37.5) 692 (53.3) 1,178 (24.4)
45 – 64 165 (29.3) 1,138 (33.6) 225 (17.3) 1,527 (31.7)
65+ 6 (1.1) 546 (16.1) 78 (6.0) 1,711 (35.5)
Missing 1 (0.0) 0 (0.0) 1 (0.0) 0 (0.0)
Previous TB disease
Yes 33 (5.9) 187 (5.5) 6 (5.1) 268 (5.6)
No 529 (94.0) 3,198 (94.4) 1,230 (94.7) 4,550 (94.4)
Missing 1 (0.2) 3 (0.1) 3 (0.2) 3 (0.1)
Homeless
Yes 106 (18.8) 265 (7.8) 37 (2.9) 372 (7.7)
No 445 (79.0) 3,115 (92.0) 1,250 (96.2) 4,428 (91.9)
Missing 12 (2.1) 8 (0.2) 12 (0.9) 21 (0.4)
Drug use (injecting)
Yes 48 (8.5) 42 (1.2) 6 (0.5) 92 (1.9)
No 432 (76.7) 3,069 (90.6) 1,229 (94.6) 4,024 (83.5)
Missing 83 (14.7) 277 (8.2) 64 (4.9) 705 (14.6)
Drug use (non-injecting)
Yes 171 (30.4) 364 (10.7) 40 (3.1) 540 (11.2)
No 311 (55.2) 2,761 (81.5) 1,192 (91.8) 3,591 (74.5)
Missing 81 (14.4) 263 (7.8) 67 (5.2) 690 (14.3)
Excess alcohol use
Yes 210 (37.3) 864 (25.5) 89 (6.9) 1,165 (24.2)
No 278 (49.4) 2,289 (67.6) 1,143 (88.0) 2,993 (62.1)
Missing 75 (13.2) 235 (6.9) 67 (5.2) 663 (13.8)
* Excluding 292 (4.6%) with concomitant pulmonary and extrapulmonary disease; among remaining TB cases, 2,173 (33.5%) were not tested for HIV 
and 4 (0.1%) were missing foreign birth status.
† Laboratory: positive M. tuberculosis culture or positive acid-fast stain; Clinical: positive tuberculin skin test, signs and symptoms consistent with TB, 
treatment with TB medication, and a completed diagnostic evaluation; Provider: cases that do not meet the laboratory or clinical case definition, but 
have a clinical picture consistent with TB.
‡ Time in US prior to diagnosis among foreign born cases (n = 1,299).BMC Public Health 2008, 8:107 http://www.biomedcentral.com/1471-2458/8/107
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3.71). Among the foreign born, HIV infection was associ-
ated with EPTB among those from the Americas region
(OR 5.12; 95% CI 2.84, 9.23). The association could not
be assessed for 4 regions because of small numbers of HIV
co-infected patients.
Discussion
This study analyzed and quantified the individual and
joint associations of HIV infection and foreign birth with
EPTB while controlling for important confounders. We
observed that foreign born TB cases were more likely to
have exclusive EPTB than US born TB cases, even in the
absence of HIV infection. HIV infection was also associ-
ated with exclusive EPTB above and beyond the effects of
race/ethnicity or geographic region for Black/African
Americans and foreign born cases from the Americas. We
also found that the site of EPTB differed by region and HIV
status. Lymphadenitis accounted for a disproportionate
Distribution of disease site by region of birth Figure 2
Distribution of disease site by region of birth. * Includes Bone/Joint, Genitourinary, Meningeal, Miliary, Peritoneal, Pleural and 
other non-specified sites.
East Asia (n=119)
Southeast Asia (n=188) United States (n=4,821)
Europe/Middle East (n=44) Africa (n=162) Americas (n=663)
India (n=103)
Lymphatic Other extrapulmonary* Pulmonary
Table 3: Distribution of extrapulmonary disease by HIV status and foreign birth*.
Extrapulmonar
y site
All EPTB cases (%) 
n = 1,366
HIV + (%) n = 
151
HIV- (%) n = 
757
P value† Foreign born (%) 
n = 402
US born (%) n = 
964
P value†
Bone and/or joint 164 (12.0) 4 (2.7) 96 (12.7) .003 48 (11.9) 116 (12.0) .96
Genitourinary 78 (5.7) 5 (3.3) 40 (5.3) .31 24 (6.0) 54 (5.6) .79
Lymphatic: 
cervical
215 (15.7) 30 (19.9) 131 (17.3) .45 119 (29.6) 96 (10.0) <.001
Lymphatic: other 147 (10.8) 28 (18.5) 70 (9.3) .008 41 (10.2) 106 (11.0) .66
Meningeal 66 (4.8) 6 (4.0) 39 (5.2) .54 21 (5.2) 45 (4.7) .66
Miliary 158 (11.6) 38 (25.2) 87 (11.5) <.001 35 (8.7) 123 (12.8) .03
Other 135 (9.9) 15 (10.0) 73 (9.6) .91 40 (10.0) 95 (9.9) .96
Peritoneal 60 (4.4) 7 (4.6) 40 (5.3) .74 12 (3.0) 48 (5.0) .10
Pleural 343 (25.1) 18 (11.9) 181(23.9) .001 62 (15.4) 281 (29.2) <.001
* 458 (33.5%) of EPTB cases were missing HIV status.
† Chi-square p-value for each category compared to all othersBMC Public Health 2008, 8:107 http://www.biomedcentral.com/1471-2458/8/107
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amount of EPTB among foreign born cases from East and
Southeast Asian, Indian, and African regions. Miliary dis-
ease and non-cervical lymphadenitis were more common
among HIV co-infected cases.
Others have also documented an association between
EPTB and foreign birth. Wilbershied et al. observed ORs,
adjusted for HIV infection and other covariates, ranging
from 0.9 to 3.9 for the association of exclusive EPTB with
foreign born populations in New York City [9]. They did
not account for race/ethnicity among the US born cases,
which is an important limitation given we found that the
occurrence of EPTB may differ by race/ethnicity.
A study of EPTB in Canada by Yang et al. found similar
associations between foreign born status and EPTB, with
crude ORs ranging from 1.72 to 2.53, when compared to
non-Aboriginal Canadians [17]. HIV status was not
adjusted for as only 1.8% of TB cases had HIV co-infec-
tion. Patients with both pulmonary and extrapulmonary
TB (8.3%) were included in the pulmonary TB group as
opposed to being excluded as in our study.
Ong et al. reported an OR of 1.62 for the association of
foreign birth with exclusive EPTB among TB cases in San
Francisco [8], but the finding was not statistically signifi-
cant. Their findings were adjusted for HIV status and race/
ethnicity, but did not account for region of birth among
foreign born TB cases.
Similar to our findings, others have observed an associa-
tion between EPTB and HIV. Ong et al. and Wilberschied
et al. found small associations, with ORs of 1.3 to 1.45
while adjusting for foreign birth [8,9]. Onorato et al.
reported that HIV infected persons were twice as likely to
have EPTB as HIV uninfected persons [11], and Yang et al.
found that those with HIV infection had nearly 5 times
the odds of EPTB than HIV uninfected TB cases [10]. These
last two studies, however, included cases with concomi-
tant PTB in the EPTB category. Concomitant pulmonary
and extrapulmonary disease has been shown to be more
common in HIV infected persons [7], which may explain
the stronger association they observed.
While EPTB among HIV infected persons is related to
immunosuppression, little is known about the factors
associated with EPTB among foreign born populations.
Some authors have speculated that this is an artifact of
screening immigrants for PTB, which could inflate the
proportion of EPTB by removing or treating those with
PTB prior to immigration [18,19]. We feel this is unlikely,
as such an affect would be seen mainly in the first year of
immigration, while our and other data [9] suggest that
EPTB occurs more often among immigrants who have
been in the US more than 5 years. Other factors such as
genetic variations in Mycobacterium tuberculosis and/or
genetic variations in host immune response may account
for the observations. Yang et al. found that TB patients
infected with M. tuberculosis (MTB) containing a mutation
in the phospholipase-C gene D had more than two times
the odds of having extrathoracic TB (with or without tho-
racic involvement) compared to those with the wild type
strain (OR 2.19; 95% CI 1.27, 3.76), while controlling for
HIV infection, sex and race [20]. Other studies have found
genetic polymorphisms in host immune responses that
are associated with EPTB, including Manose-Binding Pro-
tein and TB meningitis [21], Interleuken (IL)-1β/IL-1R
[22], IL-10 and IFN-γ [23], and NRAMP1 and pleural TB
[24]. Fernando et al. found an association between a pol-
ymorphism in the P2X7 gene and EPTB [25]. P2X7 is a
receptor expressed on macrophages which facilitates
induction and death of MTB. Polymorphisms that inhibit
Table 4: Odds ratios for each category of exposure and the association with EPTB.
HIV Uninfected HIV Infected
Race/ethnicity, Region N (%) Crude OR (95% CI)* Adj. OR (95% CI)* N (%) Crude OR (95% CI)* Adj. OR (95% CI)*
United States White 696 (17.7) Referent Referent 43 (1.1) 2.36 (1.17, 4.76) 1.04 (0.38, 2.79)
United States Black 1,638 (41.7) 1.67 (1.31, 2.13) 1.84 (1.42, 2.39) 419 (10.7) 1.89 (1.38, 2.58) 2.60 (1.83, 3.71)
United States Hispanic 65 (1.7) 1.24 (0.63, 2.46) 1.18 (0.56, 2.48) 7 (0.2) 4.58 (1.01, 20.76) 3.30 (0.54, 20.19)
United States Other 40 (1.0) 1.08 (0.44, 2.63) 1.13 (0.45, 2.83) 2 (0.1) n/a n/a
Africa 123 (3.1) 3.28 (2.14, 5.03) 2.28 (1.45, 3.59) 21 (0.5) 1.44 (0.47, 4.36) 0.97 (0.32, 3.00)
Americas 482 (12.3) 1.72 (1.27, 2.33) 1.36 (0.97, 1.91) 64 (1.6) 5.73 (3.36, 9.79) 5.12 (2.84, 9.23)
East Asia 79 (2.0) 2.36 (1.38, 4.03) 1.62 (0.93, 2.80) 0 (0.0) n/a n/a
Europe/Middle East 28 (0.7) 4.58 (2.10, 9.97) 3.38 (1.47, 7.76) 0 (0.0) n/a n/a
India 75 (1.9) 7.77 (4.69, 12.85) 5.09 (3.01, 8.60) 0 (0.0) n/a n/a
Southeast Asia 147 (3.7) 3.98 (2.68, 5.90) 2.88 (1.90, 4.37) 2 (0.1) 6.10 (0.38, 98.36) n/a
* OR, odds ratio; CI, confidence interval; Adj., adjusted for year, age, sex, injecting drug use, and alcohol use.
† Includes Asian, Pacific Islander, Alaskan Native, and American Indian.
‡ Cell counts too small to calculate associationBMC Public Health 2008, 8:107 http://www.biomedcentral.com/1471-2458/8/107
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receptor activity may facilitate the spread of MTB to
extrapulmonary sites. Among Southeast Asian refugees in
Australia, those with EPTB were more likely to have the
polymorphism than healthy controls or patients with pul-
monary TB (OR 3.8; 95% CI 1.6, 9.0).
Potential limitations of our study should be acknowl-
edged. HIV testing was not done for 35.5% of the reported
TB cases in our study. This has been noted in other studies
analyzing surveillance data, with 30% to 50% of TB
patients having unknown HIV status [9,10,26]. However,
this is unlikely to affect validity and reliability of the data
as noted in a recent analysis of California's TB registry
[27]. While HIV testing and counseling is offered free of
charge to TB patients at the health departments, incom-
plete implementation of routine HIV testing likely
accounts for why many patients were not tested. The
patient may not have been offered an HIV test due to per-
ceived low risk by the clinician, or the patient may have
refused testing when offered. Either of these scenarios
would result in missing HIV data. In our study, 54% of
patients not tested for HIV were at low risk for HIV (>44
years old with no reported substance abuse or homeless-
ness). Nevertheless, testing improved during the study
period with 92% of TB cases reported in 2006 receiving
HIV testing (Figure 3).
Small numbers of HIV co-infected TB patients hindered
our ability to analyze EPTB among foreign born persons
with HIV infection, and the absence of CD4 count data
precluded a more detailed analysis by level of immunosu-
pression. This may be important as some studies have
shown that EPTB, especially disseminated or meningeal
disease, occurs more often in individuals with cell counts
less than 200 cells/μl [28-30], even though other studies
found no association between frequency of EPTB and
decreasing CD4+ cell counts [31-33].
Conclusion
Extrapulmonary TB poses an important hurdle for the
elimination of TB in the US. The proportion of EPTB will
likely increase as foreign born and HIV attributable TB
cases continue to rise in the US. Morbidity and mortality
may be exacerbated in this group because of stigma, lan-
guage, cultural, or immigration-related barriers to timely
healthcare. Further research is needed to explore why the
occurrence and type of EPTB differs by region of birth and
whether host genetic and/or bacterial variation can
explain these differences in EPTB.
Decline in percent of TB patients not tested for HIV infection, North Carolina, 1993–2006 Figure 3
Decline in percent of TB patients not tested for HIV infection, North Carolina, 1993–2006.
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Appendix: Countries of origin and the 
corresponding region for all Tuberculosis cases 
used in the analysis
African:  Algeria, Benin, Burkina, Cameroon, Chad,
Comoros, Congo, Democratic Republic of Congo, Dji-
bouti, Egypt, Ethiopia, Europa Island, Gabon, Gambia,
Ivory Coast, Kenya, Liberia, Mauritius, Mayotte, Morocco,
Niger, Nigeria, Reunion, Senegal, Sierra Leone, Somalia,
South Africa, Sudan, Togo, Uganda, Zambia.
American: Argentina, Barbados, Brazil, Cayman Islands,
Colombia, Costa Rica, Cuba, Dominican Republic, Ecua-
dor, El Salvador, Guadeloupe, Guatemala, Haiti, Hondu-
ras, Mexico, Nicaragua, Panama, Peru, Trinidad and
Tobago, Uruguay, Venezuela.
East Asian: China, Hong Kong, Japan, North and South
Korea, Macau, Nauru, Philippines, Pitcairn Islands, Tai-
wan.
European/Middle Eastern: Albania, Azerbaijan, Belarus,
Bosnia and Hercegovina, France, Georgia, Germany,
Greece, Iran, Ireland, Kazakhstan, Kuwait, Monaco,
Oman, Romania, San Marino, Slovenia, Soviet Union,
Spain, Syria, Turkey, Ukraine, United Arab Emirates.
Indian: India, Pakistan.
Southeast Asian: Bangladesh, Burma, Cambodia, Indo-
nesia, Laos, Malaysia, Nepal, Thailand, Vietnam.
United States: United States of America.
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